Clinical trial
Comparison Between Two Different Doses of Intravenous Magnesium Sulfate for Prevention of Post-Spinal Shivering During Cesarean Section: A Double-Blind Randomized Clinical Trial
NCT07913828 is registered in ClinicalTrials.gov with Suez Canal University as lead sponsor.
Follow this trial by email Email me the PDF
Summary
Not yet recruiting, started November 2026. Interventional study, Phase 4, 82 participants (estimated). Lead sponsor Suez Canal University; Egypt. Primary measure: Incidence of Clinically Significant Post-Spinal Shivering (Crossley-Mahajan Grade ≥3).
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison Between Two Different Doses of Intravenous Magnesium Sulfate for Prevention of Post-Spinal Shivering During Cesarean Section: A Double-Blind Randomized Clinical Trial
- Lead sponsor
- Suez Canal University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- November 2, 2026
- Completion date
- December 15, 2026
- Enrollment
- 82 (estimated)
- Sites
- 1
Conditions
As the registry lists them.
post spinal anesthesia shivering
Who could take part, where it ran, who ran it
As filed in ClinicalTrials.gov.
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 40 Years
- Healthy volunteers
- No
- Study type
- Interventional
- Sites
- 1
- Countries
- Egypt
- Lead sponsor
- Suez Canal University
Arms
As registered; 2 arms.
| Arm | Type | Interventions |
|---|---|---|
| Group A (Magnesium Sulfate 50 mg/kg) | Experimental | Magnesium Sulfate 50 mg/kg IV |
| Group B (Magnesium Sulfate 30 mg/kg) | Active comparator | Magnesium Sulfate 30 mg/kg IV |
Primary endpoints
Registered primary outcome measures; 1 primary.
| Measure | Time frame |
|---|---|
| Incidence of Clinically Significant Post-Spinal Shivering (Crossley-Mahajan Grade ≥3) | From immediately after spinal anesthesia until 60 minutes after spinal anesthesia |
Lead sponsor's other trials
Suez Canal University, most recent start first.
+158 more trials See the organization page